Endothelial NADPH oxidases: which NOX to target in vascular disease?
- PMID: 25066192
- DOI: 10.1016/j.tem.2014.06.012
Endothelial NADPH oxidases: which NOX to target in vascular disease?
Abstract
NADPH oxidases (NOXs) are reactive oxygen species (ROS)-generating enzymes implicated in the pathophysiology of vascular diseases such as hypertension and stroke. Endothelial cells express four NOX isoforms including the superoxide-generating enzymes NOX1, NOX2, and NOX5 and the hydrogen peroxide-generating enzyme NOX4. Studies on arteries from patients with coronary artery disease, and in animals with experimentally induced hypertension, diabetes, or atherosclerosis, suggest that NOX1, NOX2, and NOX5 promote endothelial dysfunction, inflammation, and apoptosis in the vessel wall, whereas NOX4 is by contrast vasoprotective in increasing nitric oxide bioavailability and suppressing cell death pathways. Based on these findings and promising preclinical studies with the NOX1/NOX2 antagonist, apocynin, we suggest that the field is poised for clinical evaluation of NOX inhibitors as therapeutics for cardiovascular disease.
Keywords: NADPH oxidases; diabetes; endothelial dysfunction; hyperlipidemia; hypertension; inflammation; reactive oxygen species; selective NOX1/2 inhibitors; vascular disease.
Copyright © 2014 Elsevier Ltd. All rights reserved.
Similar articles
-
Reactive oxygen species and endothelial function--role of nitric oxide synthase uncoupling and Nox family nicotinamide adenine dinucleotide phosphate oxidases.Basic Clin Pharmacol Toxicol. 2012 Jan;110(1):87-94. doi: 10.1111/j.1742-7843.2011.00785.x. Epub 2011 Sep 28. Basic Clin Pharmacol Toxicol. 2012. PMID: 21883939 Review.
-
The emerging role of NADPH oxidase NOX5 in vascular disease.Clin Sci (Lond). 2017 May 1;131(10):981-990. doi: 10.1042/CS20160846. Clin Sci (Lond). 2017. PMID: 28473473 Review.
-
Molecular mechanisms of hypertension: role of Nox family NADPH oxidases.Curr Opin Nephrol Hypertens. 2009 Mar;18(2):122-7. doi: 10.1097/MNH.0b013e32832923c3. Curr Opin Nephrol Hypertens. 2009. PMID: 19430333 Review.
-
Expression of NADPH oxidases and enhanced H(2)O(2)-generating activity in human coronary artery endothelial cells upon induction with tumor necrosis factor-alpha.Int Immunopharmacol. 2008 Oct;8(10):1377-85. doi: 10.1016/j.intimp.2008.05.004. Epub 2008 Jun 4. Int Immunopharmacol. 2008. PMID: 18687299
-
Unchanged NADPH Oxidase Activity in Nox1-Nox2-Nox4 Triple Knockout Mice: What Do NADPH-Stimulated Chemiluminescence Assays Really Detect?Antioxid Redox Signal. 2016 Mar 1;24(7):392-9. doi: 10.1089/ars.2015.6314. Epub 2015 Jun 30. Antioxid Redox Signal. 2016. PMID: 25906178 Review.
Cited by
-
Potential use of antioxidants for the treatment of chronic inflammatory diseases.Front Pharmacol. 2024 May 16;15:1378335. doi: 10.3389/fphar.2024.1378335. eCollection 2024. Front Pharmacol. 2024. PMID: 38818374 Free PMC article. Review.
-
Effects of Nox4 upregulation on PECAM-1 expression in a mouse model of diabetic retinopathy.PLoS One. 2024 May 15;19(5):e0303010. doi: 10.1371/journal.pone.0303010. eCollection 2024. PLoS One. 2024. PMID: 38748682 Free PMC article.
-
Resilience to diabetic retinopathy.Prog Retin Eye Res. 2024 Jul;101:101271. doi: 10.1016/j.preteyeres.2024.101271. Epub 2024 May 11. Prog Retin Eye Res. 2024. PMID: 38740254 Free PMC article. Review.
-
Endothelial Reprogramming in Atherosclerosis.Bioengineering (Basel). 2024 Mar 27;11(4):325. doi: 10.3390/bioengineering11040325. Bioengineering (Basel). 2024. PMID: 38671747 Free PMC article. Review.
-
Inositol Hexaphosphate as an Inhibitor and Potential Regulator of p47phox Membrane Anchoring.Biochemistry. 2024 May 7;63(9):1097-1106. doi: 10.1021/acs.biochem.4c00117. Epub 2024 Apr 26. Biochemistry. 2024. PMID: 38669178 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous